Evaluación de Tecnologías Sanitarias

Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB

T. Peasgood,C. Mukuria,J. Brazier,O. Marten,S. Kreimeier,N. Luo,B. Mulhern,W. Greiner,A. S. Pickard,F. Augustovski,L. Engel,L. Gibbons,Z. Yang,A. L. Monteiro,M. Kuharic,M. Belizan and J. Bjørner. Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB. Value Health. 2022;25(4):10.1016/j.jval.2021.11.1361.

Developing a New Generic Health and Wellbeing Measure: Psychometric Survey Results for the EQ-HWB Ver más »

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force

W. Oortwijn,D. Husereau,J. Abelson,E. Barasa,D. D. Bayani,V. C. Santos,A. Culyer,K. Facey,D. Grainger,K. Kieslich,D. Ollendorf,A. Pichon-Riviere,L. Sandman,V. Strammiello and Y. Teerawattananon. Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force. Int J Technol Assess Health Care. 2022;38(1):10.1017/s0266462322000198.

Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force Ver más »

Demographic and clinical characteristics of individuals with traumatic spinal cord injury in Argentina from 2015 to 2019: a multicenter study

M. A. Gatti,M. P. Sampayo,A. Rolandelli,S. Yannone,F. J. Argento,M. E. Rivas,M. S. Broggi,L. E. Olmos and P. Gorman. Demographic and clinical characteristics of individuals with traumatic spinal cord injury in Argentina from 2015 to 2019: a multicenter study. Spinal Cord Ser Cases. 2020;6(1):10.1038/s41394-020-00362-6.

Demographic and clinical characteristics of individuals with traumatic spinal cord injury in Argentina from 2015 to 2019: a multicenter study Ver más »

Defining the value of health technologies in Latin America: Development in value frameworks to inform the prioritization of health care resources

A. Pichon-Riviere,S. Garcia-Marti,W. Oortwijn,F. Augustovski and L. Sampietro-Colom. Defining the value of health technologies in Latin America: Development in value frameworks to inform the prioritization of health care resources. International Journal of Technology Assessment in Health Care. 2019;35(1):10.1017/s0266462319000126.

Defining the value of health technologies in Latin America: Development in value frameworks to inform the prioritization of health care resources Ver más »

Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios

A. Pichon-Riviere,S. Garcia-Marti,W. Oortwijn,F. Augustovski and L. Sampietro-Colom. Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios. Int J Technol Assess Health Care. 2019;35(1):10.1017/s0266462319000126.

Definiendo el valor de las tecnologías sanitarias en Latino-América: desarrollo de marcos de valor para informar la priorización de recursos sanitarios Ver más »

COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL

A. Pichon-Riviere,J. Caporale,C. von Schulz-Hausmann and F. A. Augustovski. COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL. Value in Health. 2009;12(7):10.1016/s1098-3015(10)75391-2.

COSTS OF INSULIN GLARGINE AND INSULIN DETEMIR IN INTENSIVE INSULIN THERAPY FOR TYPE 1 DIABETES MELLITUS IN ARGENTINA: A PROBABILISTIC MODEL Ver más »

Cost-Effectivity of Implantable Cardioverter Defibrillators in Patients with Risk Factors for Sudden Death in Argentina

A. Alcaraz,J. Gonzalez-Zuelgaray and F. Augustovski. Cost-Effectivity of Implantable Cardioverter Defibrillators in Patients with Risk Factors for Sudden Death in Argentina. Value in Health. 2011;14(5):10.1016/j.jval.2011.05.030.

Cost-Effectivity of Implantable Cardioverter Defibrillators in Patients with Risk Factors for Sudden Death in Argentina Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela

S. G. Marti,A. Alcaraz,P. Valanzasca,O. U. Garay,M. McMullen,L. R. Ares,C. A. Obando and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS-C VIRUS INFECTION IN VENEZUELA. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis-C Virus Infection in Venezuela Ver más »

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile

S. G. Marti,A. Alcaraz,P. Valanzasca,U. G. Ulises,M. McMullen,L. R. Ares,I. Peirano,D. O. Reisberg,A. S. Ried,J. Poniachik,J. R. B. Barril and J. Caporale. COST-EFFECTIVENESS OF TELAPREVIR IN GENOTYPE 1 CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN CHILE. Value in Health. 2013;16(7).

Cost-Effectiveness of Telaprevir in Genotype 1 Chronic Hepatitis C Virus (HCV) Infection in Chile Ver más »